Amiloxate

Amiloxate is a sunscreening agent. It is approved for use in the European Union and is undergoing regulatory evaluation in the United States.[1][2]

Amiloxate

Names
IUPAC name 3-Methylbutyl (2E)-3-(4-methoxyphenyl)acrylate
Other names Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate
Identifiers
CAS Number	71617-10-2
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL1476782
ChemSpider	1266578
ECHA InfoCard	100.068.798
PubChem CID	1549789
UNII	376KTP06K8
CompTox Dashboard (EPA)	DTXSID1046055
InChI InChI=1S/C15H20O3/c1-12(2)10-11-18-15(16)9-6-13-4-7-14(17-3)8-5-13/h4-9,12H,10-11H2,1-3H3/b9-6+ Key: UBNYRXMKIIGMKK-RMKNXTFCSA-N InChI=1/C15H20O3/c1-12(2)10-11-18-15(16)9-6-13-4-7-14(17-3)8-5-13/h4-9,12H,10-11H2,1-3H3/b9-6+ Key: UBNYRXMKIIGMKK-RMKNXTFCBL
SMILES CC(C)CCOC(=O)/C=C/C1=CC=C(C=C1)OC
Properties
Chemical formula	C15H20O3
Molar mass	248.322 g·mol^−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

See also

• Octyl methoxycinnamate

References

1. Brian Palmer. "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
2. Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News. 92 (19): 27.